Archive | August, 2017

David Stiles: HTM’s Essential Role in Disaster Preparedness

August 28, 2017

3 Comments

This past week, we experienced two major natural events that affected a large part of our nation. First, the rapid trajectory of our sun and moon across our continent created, for many, a once-in-a-lifetime opportunity to see a full solar eclipse. But then, the slow and lumbering trajectory of Hurricane Harvey across the Texas Gulf […]

Continue reading...

Pat Baird and Erin Sparnon: When It Comes to Cybersecurity, You Can’t Do It Alone

August 24, 2017

3 Comments

You oughta see the view from my silo! During this summer’s AAMI 2017 Conference & Expo, we were excited to again be the facilitators for the session, Top 10 Issues Facing HTM. Every year, we pose questions to the audience regarding emerging HTM issues, and the audience members share their experiences and practices. And, every […]

Continue reading...

Larry Fennigkoh: It’s Past Time for HTM to Turn Data into Knowledge

August 11, 2017

6 Comments

How do you scientifically determine the effect of something on something else? The answer (in whatever form it may take and regardless of the branch of science from which it originates) may often be answered through use of a well-established statistical technique referred to as regression analysis. It is through the application and appropriate use […]

Continue reading...

Alan Lipschultz: Are You Ready? Two Big Changes on the Horizon for HTM

August 9, 2017

4 Comments

Two standards in development will, if approved, significantly impact the healthcare technology management (HTM) field. If they aren’t already on your organization’s radar, they should be. The first one involves a push by medical device manufacturers to get hospital-based and non–manufacturer-based service organizations to follow some of the quality systems requirements that manufacturers currently follow. […]

Continue reading...

William Hyman: Reauthorization Bill Calls for FDA Report on Medical Device Service

August 8, 2017

2 Comments

The FDA Reauthorization Act of 2017 completed its passage through Congress on Aug. 3, and the bill will become law once signed by President Trump. Although a major focus of this legislation is FDA user fees that are paid by manufacturers, it also addresses a number of other topics, including a favorite of everyone involved […]

Continue reading...

Mike Ahmadi: When It Comes to Cybersecurity, the Regulatory Will Is Weak

August 3, 2017

1 Comment

I want to tell a story. I grew up in Cleveland Ohio, a city that has always held its place in the top two or three cities that everyone likes to poke fun at for being a place where you do not want to live—or so it was for most of my life. Thankfully, it […]

Continue reading...

Paul Kelley: Of Crabs, Crawdads, and HTM

August 1, 2017

3 Comments

Have you ever seen a bucket of crabs or crawdads? You can put them all in the bucket and not worry about any escaping because as one tries to crawl up and out of the bucket, the others grab it and pull it back. It’s akin to a mindset of, “If I can’t have it, […]

Continue reading...